NEWPATHS Trademark

Trademark Overview

On Wednesday, June 14, 2023, a trademark application was filed for NEWPATHS with the United States Patent and Trademark Office. The USPTO has given the NEWPATHS trademark a serial number of 98041778. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, November 5, 2024. This trademark is owned by CSL Behring L.L.C.. The NEWPATHS trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis

Providing medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
newpaths

General Information

Serial Number98041778
Word MarkNEWPATHS
Filing DateWednesday, June 14, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesEducational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
Pseudo MarkNEW PATHS
Goods and ServicesProviding medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring L.L.C.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406
Party NameCSL Behring L.L.C.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKing of Prussia, PA 19406

Trademark Events

Event DateEvent Description
Tuesday, July 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 20, 2024ASSIGNED TO EXAMINER
Monday, February 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Saturday, June 17, 2023NEW APPLICATION ENTERED
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU EXTENSION 1 FILED
Tuesday, November 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

newpaths conditions inflammatory diseases neutrophil which palmoplantar pustulosis potentially suppurative pathophysiology